Marksans Pharma Ltd has announced that a meeting of the Board of Directors of the Company will be held on September 16, 2008, to make allotment of 8400241 Equity shares of Re 1/- to M/s. Bamacle LLc on preferential allotment basis, if approved by the shareholders at the Extra Ordinary General Meeting to be held on September 10, 2008.